NAMPT and neoplasm: Because of the multifaceted and pathway-connecting role of NAD in the cell, the rate-limiting enzyme for NAD synthesis, nicotinamide phosphoribosyl transferase (NAMPT), has been identified as a target for tumor therapy [45, 46].